In addition to THC, the CBD theme is also discussed in relation to the therapeutic benefit of cannabis on a regular basis. The Liposomal CBD Oil does not produce any cerebral effects. Therefore, for many patients it represents an excellent, and even preferred, choice of treatment for their symptoms. Here you can read how the Liposomal CBD Oil can be used in medicine.
The cannabinoid CBD is known for its antiemetic properties, antipsychotic, anti-inflammatory, detoxifying, anxiolytic, tumor inhibitors, and antidepressants. These are sufficient reasons for further research into how the Liposomal CBD Oil can be used in medicine.
The Liposomal CBD Oil in medicine: Pediatric Childhood epilepsy
Liposomal CBD Oil helps suppress pain, psychosis and seizures or epileptic seizures. Studies have been conducted in both Israel and the U.S. that show that CBD-rich cannabis has medical applications in relieving epilepsy symptoms.
An 89% reduction in the frequency of attacks
74 children and adolescents, aged between 1 and 18, who failed traditional methods of epilepsy treatment were treated, in Israel in 2014, with rich-CBD cannabis. On average, patients took Liposomal CBD Oil for 6 months. The proportion of CBD-THC was 20:1, and the substances were dissolved in olive oil. They were given between 1 and 20mg a day per kilogram of body weight.
The frequency of attacks during the study was observed, which was recorded by the patients ‘ parents. The results of the study were as follows: In 89% of the patients (66 of 74), the frequency of the attacks was reduced. Parents of 13 children (18%) indicated that the frequency of seizures had decreased by 75–100%. The attacks of twenty-five patients (34%) were 50–75% less frequent; 9 (12%) saw their crises reduced by 25–50%; and 19 (26%) saw theirs reduced by 25%. In 5 patients (7%) of the 74 totals, it was reported that the severity of the attacks increased with the administration of Liposomal CBD Oil, so treatment was interrupted.
Researchers also observed an improvement in behavior, alertness, language, communication, motor skills, and patient sleep. Side effects of taking Liposomal CBD Oil included drowsiness, fatigue, gastrointestinal problems and irritability, which led to the abandonment of cannabis use in five patients.
The result of the study is as follows: “The results of this multicentric study on the treatment of intreatable epilepsy with CBD in a population of children and adolescents are very promising. More prospective, well-designed clinical studies are needed on the use of medicinal cannabis enriched with Liposomal CBD Oil.
Average reduction of motor crises by 36.5%
The history of this study on the Liposomal CBD Oil conducted in 2014–2015 is based on the fact that almost one-third of patients with epilepsy suffer from a treatment-resistant form of the disease. According to recent estimates, 2.2 million people live with epilepsy in the U.S. alone. This means that traditional epilepsy medicines do not help more than 733,000 patients at all or to a satisfactory degree. The goal of studies in eleven different epilepsy centers in the US was to determine whether cannabis treatments are safe, tolerable and effective in children and young adults with treatment-resistant epilepsy. In total, 214 young patients aged between 1 and 30 years who were administered CBD for at least 12 weeks participated.
At the beginning of the study, the mean frequency of attacks monthly was 30.0% compared to 15.8 during 12-week treatment with Liposomal CBD Oil. The average and monthly reduction of motor crises was 36.5%.
Liposomal CBD Oil For Dravet syndrome
In March 2016, the British company GW Pharmaceuticals announced that it had completed the first part of a three-phase study of the Epidiolex drug, with a positive result. In total, 120 people participated. It was treated in half with the drug based on cannabidiol, and the other half was treated with a placebo. In patients undergoing treatment with Epidiolex, an average reduction in the monthly frequency of attacks of 39% was achieved. In patients undergoing placebo treatment, the equivalent figure was 13%.
“The results of this pivotal clinical trial of Epidiolex are important and exciting as they represent the first placebo-controlled evidence that supports the safety and efficacy of pharmaceutical cannabidiol in children with Dravet syndrome, one of the More severe and difficult to treat types of epilepsy, “said Dr. Devinsky, a medical Doctor at the Langone Integral Epilepsy Center at New York University.
In the second part of the 3-phase study, another 150 young patients suffering from Dravet syndrome are being treated with Epidiolex. In addition, GW Pharmaceuticals is testing the drug in a global clinical trial in patients with Lennox-Gastaut syndrome. The results of this study will be published later this year 2016.
The Liposomal CBD Oil in medicine: Schizophrenia
Liposomal CBD Oil may be a therapeutic option for people suffering from schizophrenia, as one-third of patients with mental illness fail to maintain their symptoms sufficiently controlled with antipsychotic drugs. Standardized. Schizophrenia is characterized by disorders affecting perception, cognition, functions of the ego, will, affection, motivation and psychomotor function.
It was found that a significant proportion of patients with schizophrenia suffer a number of natural anomalies and metabolic iatrogenic — iatrogenic means caused by medical treatment — such as obesity, type 2 diabetes, intolerance to Glucose and lipid metabolism disorder. In addition, schizophrenic patients are often affected by chronic systemic inflammations, Cushing’s syndrome (HIPERADRENALISMO), and excessive stress reactions.
Since the Endocannabinoid system (sec) of the brain is responsible for maintaining mental health — among other functions — and cannabis is known to affect the SEC, researchers believe that cannabis is a possible therapeutic option in these cases. The endocannabinoid system regulates emotions, sleep, reward system and aversive memory. The Liposomal CBD Oil in medical practice can have a positive effect on the metabolic, anti-inflammatory, and stress-related components of schizophrenia.
Improved signaling of anandamide
In 2012, researchers found that cannabidiol improves anandamide signage and relieves psychotic symptoms of schizophrenia. The results of a clinical study suggest that inhibition of anandamide deactivation may contribute to the antipsychotic effects of cannabidiol, potentially representing a completely new mechanism in the treatment of schizophrenia.
The Anandamide — Ananda is the Sanskrit word for the absence of unhappiness, in other words, happiness — plays an important role in the regulation of appetite and feelings of joy and gratitude. (By the way, Anandamide is also found in chocolate.) It binds to cannabinoid receptors, in addition to having an effect on pain, energy and memory regulation.
In 2014, the British firm GW Pharmaceuticals began testing with a drug called GWP42003, whose main cannabinoid is cannabidiol. Initial investigations showed antipsychotic effects in patients with schizophrenia. According to the information published by the company, the study is in phase 2, although patients criticize the fact that such medicine is only given as a complement to the antipsychotics that are already being taken. Sensi seeds will continue to report on developments.
Liposomal CBD Oil Prevents psychosis
In early 2016, Brazilian researchers found that treatment with Liposomal CBD Oil can prevent psychosis. This was discovered on the basis of animal experimentation.
The CBD Oil in medicine: The pain
Chronic and neuropathic pain
Chronic pain may be due to many causes: diabetes, multiple sclerosis, cancer, HIV, rheumatism, serious accidents, and other ailments. The treatment of pain plays a role in improving the quality of life of patients. Depending on the severity of pain, people use over-the-counter analgesics such as aspirin, ibuprofen, diclofenac, and paracetamol. In many cases, opiates are also used to combat pain. All these drugs have side effects.
It is estimated that 2,000 people die each year in the Federal Republic of Germany because of the side effects of analgesics. The real number is much higher. America’s figures are even more alarming. According to CDC — The Centers for Disease Control and prevention — prescription opioid-related overdose deaths have quadrupled since 1999. From 1999 to 2014, more than 165,000 people have died in the U.S. for opiate-related overdoses obtained under medical prescription. In 2014, nearly 2 million Americans were dependent on prescribed opioids.
Liposomal CBD Oil reduces Hyperalgesia
Already in 2007, researchers discovered in animal testing that daily Liposomal CBD Oil administration resulted in a reduction in hyperalgesia (pain sensitivity and excessive painful stimulus reaction). The potential for the therapeutic use of the CBD in chronic pain was described at the time of the study outcome.
Less pain, less opiates and improved quality of life
A current study, conducted in Israel, confirms that cannabis reduces pain and the use of opiates, as well as improving patients ‘ quality of life. In summary, 274 patients participated in the study, although it should be mentioned that patients were not given pure Liposomal CBD Oil, but medical cannabis in general, which also includes THC (and other cannabinoids). However, the results are very promising:
After six months, the score of pain symptoms had dropped from an average of 83.3 to a 75.0. The pain intensity score also improved. The need for opiates decreased over the course of the observation period by approximately 44%. The positive results of the study suggest a long-term benefit of cannabis in this group of patients, researchers said.
Medicinal Cannabis Instead Of Opioids
Between November 2013 and February 2015, a series of questions were made to 244 cannabis patients suffering from chronic pain through an online questionnaire in Michigan. The consumption of medicinal cannabis was related to a reduction of 64% in the consumption of opioids, fewer side effects and an improvement of the quality of life in 45% of the participants in the study. The study suggests that patients are substituting opioids for medicinal cannabis. They also report that they believe that the advantages and side effects of medicinal cannabis are more significant than those of other drugs. In this case, also, it should be mentioned that they were not administered exclusively Liposomal CBD Oil, but medical cannabis in general.
Cancer-related pain, for example, is the result of inflammation and damage to the nerves, bones, and other structures that are sensitive to pain. Persistent and severe cancer-related pain tends to be resistant to opioid treatment. The Liposomal CBD Oil in medicine represents a real alternative. It has an anti-inflammatory and analgesic effect without reducing the function of the nervous system. In addition, the Liposomal CBD Oil does not reduce the efficacy of chemotherapy.
It was concluded, in numerous tests on animals performed in the past, that nerve neuropathy or damage caused by the drug paclitaxel (Taxol/PAC) during chemotherapy is reduced with the administration of CBD. Neuropathy leads to symptoms such as pain, numbness, or tingling. Liposomal CBD Oil was used in pre-treatment trials before breast cancer therapy with PAC.
The Liposomal CBD Oil in medicine: cancer
Neuroblastoma is a malignant disease of the sympathetic nervous system that occurs mainly in children. It is the third most common malignant type of tumor in children. A neuroblastoma may occur in the adrenal glands, along the spine, in the head and neck, and in the chest, abdomen, and pelvis.
Liposomal CBD Oil makes tumors reduce their size
The Liposomal CBD Oil offers a ray of hope for the treatment of affected patients. This was the conclusion of a study whose results were published in March 2016. Both THC and CBD were tested in vitro and in vivo. Both cannabinoids have properties that make tumors reduce their size, the CBD being the most active of these two cannabinoids. The results suggest that the Liposomal CBD Oil should be further investigated as an effective drug against cancer in the treatment of neuroblastoma.
In fact, research has shown that the Liposomal CBD Oil effectively inhibits the growth of several types of tumor. In addition, it inhibits signals that stimulate growth in glioma cells.
Increased motivation and satisfaction
In an experiment with rats, a “prohedónico” and increased motivational effect was found — “Prohedónico” means that it facilitates satisfaction or pleasure — and researchers were able to ascertain the existing knowledge of the CBD as an antidepressant. The results suggest that cannabidiol may prove beneficial in the treatment of clinical depression and the famous anhedonia.
In mice conduct tests, it was recently concluded that the Liposomal CBD Oil not only relieves anxiety, but is also a fast-acting antidepressant. In addition, the trials showed an increase in excitation transmission between nerve cells for cortical 5-HT/glutamate. The results of the study suggest that the CBD could be a new antidepressant, safe and fast.
The Liposomal CBD Oil in medicine: multiple sclerosis
Symptoms of multiple sclerosis include pain, spastic paralysis, depression, fatigue, and incontinence. The Liposomal CBD Oil can provide great relief from the symptoms of patients who have multiple sclerosis. Its anti-inflammatory properties were described in a study conducted in 2013, according to which the Liposomal CBD Oil provides continuous protection against the harmful effects of inflammations in viral multiple sclerosis. It has an important therapeutic potential.
The Liposomal CBD Oil in medicine: Autism
Anecdotal reports from parents of autistic children make it clear that CBD use has a positive effect on young patients. The state of the children improved both physically and mentally. Sensi Seeds has recently published a detailed article about it, that anyone who is interested can read here.